Review Article

MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives

Figure 4

Enhancing lesion (a) during immunotherapy with dendritic cell vaccine. Mismatch between T1-enhancing volume and CBV (b), the last being just slightly elevated; permeability (Ktrans) is increased (c). ADC is low (d), suggesting hypercellularity.
(a)
(b)
(c)
(d)